FDA Investigator Nicholas J Morici
Nicholas J Morici has conducted inspections on 58 sites in 1 countries as of 09 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
58
Last Inspection Date:
09 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Nicholas J Morici:
Addie V Scott Boston,
Alejandra Mcclellan,
Ali A Patino,
Amber D Brodas,
Amber G Chung,
Amy Kim,
Ann Marie Karnick,
Anthony R Rauert,
Anthony W Thomas,
Benjamin Bustamante,
Brian D Young,
Carrie E Jolly,
Christine M Rivera,
Coleburn E Vielehr,
Daniel Green,
Daniel W Johnson,
Dauksism,
David A Trent Carlson,
David R Delucia,
Devon Jenkins,
Donyel M Jones,
Edwin A Evangelista,
Erica B Raphael,
Gayle S Lawson,
Giovanni A Vigilante,
Iram R Hassan, PhD,
Jana J Lau,
Jason Kwong,
Joseph Duca,
Joseph L Despins, PhD,
Joseph S Fanelli,
Joseph T Dougherty,
Karen A Spencer,
Kelly Doremus,
Kim G Campbell,
Kristina J Donohue,
Kyle S Hobson,
Lawrence R Johnson,
Linda M Hoover,
Matthew R Noonan,
Melissa M Dauksis,
Michael A Taylor,
Neil J Bonzagni, PhD MPH,
Peter M Trunk,
Ramanda C Gregory,
Rita F Monfort,
Russell P Vandermark,
Sarah A Meehan,
Sarah K Graham,
Seemay A Lee,
Shreya Shah,
Sony Mathews,
Stephanie T Durso,
Van Cliff,
William V Thompson,
Willy A Orantes,
Yuyan Liang
Nicholas J Morici's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2024 | FDA 483 | East Bay Wholesales Corporation - Form 483, 2024-05-06 |
August, 2022 | FDA 483 | Banyan International LLC - Form 483, 2022-08-11 |
July, 2021 | EIR | MYLAN CONSUMER HEALTHCARE Inc. - EIR, 2021-07-29 |
January, 2022 | FDA 483 | Balajee Trade Link LLC - Form 483, 2022-01-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more